News


Image: illustrates output by the software Colours shown are: • Red: index lesion • Blue: prostate organ • Grey: seminal vesicles

Lucida Medical Ltd, the Cambridge based start-up, has completed CE marking for its new machine learning-based prostate cancer detection software, Prostate Intelligence (Pi). Lucida is one of the first companies in the world to commercialise artificial intelligence software to identify cancer in prostate MRI scans. This crucial milestone enables...

01-06-2021
Dr. Paolo Paoletti, CEO of GammaDelta Therapeutics

GammaDelta Therapeutics, a company focused on exploiting the unique properties of gamma delta (γδ) T cells for immunotherapy, today announced the US Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for the Company’s allogeneic variable delta 1 (Vδ1) gamma-delta (γδ) T cell therapy, GDX012, to be...

20-05-2021
biorbyt logo and 10th anniversary graphic

Biorbyt is delighted to have been honoured with a Queen’s Award for Enterprise for its outstanding achievements in international trade. This prestigious award recognises Biorbyt’s ongoing commitment to the global life sciences research community, and endorses the company’s goal of becoming the ‘go-to’ supplier for high quality biological...

20-05-2021
Mental Health First Aid with Illuminate Charity

An online course next month takes an indepth look at mental health, the factors that trigger mental ill health, practical skills and development to identify and tackle issues along with the support routes available.

14-05-2021
Colin Jones and Inger Anson

Award winning top regional law firm Harrison Clark Rickerbys (HCR) has announced it is in the advanced stages of merger talks with well-established firm Hewitsons, a move which will add new locations in Northampton and Milton Keynes to its existing network of nine offices.

13-05-2021
Amadeus team collage

Global technology investor Amadeus Capital Partners has announced the closing at £110 million of its latest early stage, deep tech investment platform, the Amadeus V Technology Fund, which includes a cornerstone commitment by British Patient Capital, the UK’s largest investor in venture and venture growth opportunities.

06-05-2021

Avacta Group plc (AIM: AVCT), the developer of diagnostics and innovative cancer therapies based on its proprietary Affimer® and pre|CISION™ platforms, is pleased to announce positive data from the clinical validation of its AffiDX® SARS-CoV-2 antigen lateral flow test. Data from the clinical study conducted in Europe on...

20-04-2021

The Government has annnounced its intention to intervene in the proposed acquisition of ARM with NVIDIA.

20-04-2021
Trucks on the highway -- Image by Markus Spiske from Pixabay

Johnson Matthey, a global leader in sustainable technologies, has joined a major new European consortium, ‘IMMORTAL’, to develop higher performance fuel cell components for heavy duty trucks with a predicted lifetime of at least 30,000 hours, enabling us to take a step closer towards decarbonising freight transport and a net zero future.

19-04-2021
Arecor logo

Arecor Limited, the biopharmaceutical company advancing today’s therapies to enable healthier lives, today announces that it  has  been  awarded  a  £2.8 million grant from Innovate UK to support the Phase II development of AT247, its ultra-rapid acting insulin product candidate which is based on Arecor’s proprietary Arestat™ technology...

31-03-2021
Recycling bins at train station

PragmatIC, a world leader in flexible electronics, has been awarded a £1.3 million contract from the UK Government Sustainable Innovation Fund for a state-of-the-art recycling scheme based on PragmatIC’s ultra-low-cost NFC technology.

30-03-2021
Professor Wolf Reik, FRS, FMedSci

Following an open and international search, Professor Wolf Reik has been appointed by the Babraham Institute Board of Trustee Directors as the Institute’s Director. Professor Reik has held the position of Acting Director since May 2020 following the tragic death of Professor Michael Wakelam.

26-03-2021
Stamp Free logo

Stamp Free Limited, the digital postage stamp company, is pleased to announce the launch of its Stamp Free Digital Postage Solution™. Initially targeted at postal and logistics sectors, the solution is the first in the world to be offered by a company that is independent of postal services.

11-03-2021
Trinity Hall, University of Cambridge

The World Travel & Tourism Council (WTTC) and Visit Britain have issued Trinity Hall with a ‘Safe Travels’ stamp in recognition of meeting international global health and hygiene protocols and for its role as a conference and events venue in supporting the recovery of UK tourism.

03-03-2021

New partnership aims to accelerate CE marking of Avacta’s SARS-CoV-2 rapid antigen test and support COVID-19 testing in low and middle income countries.

09-02-2021
 CN Bio’s proprietary PhysioMimix™ system

CN Bio, a leading developer of single and multi organ-on-chip microphysiological systems (MPS) that improve the accuracy and efficiency of drug discovery, today announced the publication of co-authored research with the US Food and Drug Administration (FDA)1.

12-01-2021

Budget proposals published by the District Council have put supporting South Cambridgeshire’s residents and businesses through the Coronavirus pandemic at their heart.

12-01-2021

Cambridge Allergy Ltd (Camallergy), a biopharmaceutical company dedicated to providing innovative, patient-centric treatments for life-threatening food allergies, announced that its manufacturing facility outside of Portsmouth, UK, was approved by the MHRA, the Medicines and Healthcare products Regulatory Agency, to manufacture its proprietary...

12-01-2021

Mologic Ltd, a leading developer of lateral flow and rapid diagnostic technologies, is pleased to announce its professional-use COVID-19 Rapid Antigen Test has been certified with a CE mark, following independent assessment by the Liverpool School of Tropical Medicine (LSTM). The test will provide health professionals an accurate detection of...

24-12-2020
Mogrify HQ

Mogrify®, the life science company transforming the development of cell therapies have grown rapidly since forming. They wanted their headquarters in The Cambridge Science Park Bio-Innovation centre to have versatility in accommodating their continued growth and to provide flexibility within the breakout areas.

 

 

21-12-2020

Pages